Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Rebecka Hellsten

4PUBLICATIONS

5CO-AUTHORS

Predictive and prognostic markersMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Nov 11, 2024

pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy.

Piotr Bialas, Tamae Kobayashi, Rebecka Hellsten

|Mar 31, 2021

Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer.

Kristina Witt, Susan Evans-Axelsson, Andreas Lundqvist

|Jul 27, 2019

The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors.

Rebecka Hellsten, Lisa Lilljebjörn, Martin Johansson

|Mar 25, 2019

Expression of tSTAT3, pSTAT3<sup>727</sup> , and pSTAT3 <sup>705</sup> in the epithelial cells of hormone-naïve prostate cancer.

Agnieszka Krzyzanowska, Nicholas Don-Doncow, Felicia Elena Marginean

Pageof 1

Frequent Collaborators

2 joint publications

Agnieszka Krzyzanowska

1 joint publications

Nicholas Don-Doncow

1 joint publications

Piotr Bialas

1 joint publications

Tuomas Mirtti

1 joint publications

Anders Bjartell

Frequent Collaborators

2 joint publications

Agnieszka Krzyzanowska

1 joint publications

Nicholas Don-Doncow

1 joint publications

Piotr Bialas

1 joint publications

Tuomas Mirtti

Top Related Videos

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on : Aug 02, 2018

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on : May 30, 2012

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on : May 20, 2015

See more related videos

Top Related Videos

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on : Aug 02, 2018

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on : May 30, 2012

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on : May 20, 2015

See more related videos